Search This Blog

Thursday, September 19, 2024

Achilles to discontinue development of TIL-based cNeT therapy

 –Cash position of $95.1 million as of June 30, 2024–

–BofA Securities engaged to provide strategic financial advice–

https://www.globenewswire.com/news-release/2024/09/19/2948865/0/en/Achilles-Therapeutics-Announces-Strategic-Update.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.